Rushad Patell
Overview
Explore the profile of Rushad Patell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patell R, Bindal P, Freed J, Dodge L, Nagaraj G, LaCasce A, et al.
J Natl Compr Canc Netw
. 2025 Mar;
23(3):82-89.
PMID: 40073833
Background: Oncology providers often lack the confidence to make clinical recommendations about medical cannabis (MC). This study aimed to develop and evaluate the feasibility of implementing an educational curriculum on...
2.
Travers H, Coden G, Simon S, Kuznetsov M, Smith E, Patell R, et al.
J Orthop
. 2025 Mar;
68:114-120.
PMID: 40060192
Aims & Objectives: The risk of postoperative venous thromboembolism (VTE) and bleeding after operative management of femoral neck fractures (FNF) is well established. It is common for FNF patients to...
3.
Chiang C, Song J, Chang Y, Osataphan S, Lee Y, Chang K, et al.
Blood Adv
. 2025 Feb;
PMID: 39908569
Glucagon-like peptide 1 receptor agonists (GLP1-RA) are anti-diabetes agents recently approved for weight loss. Obesity is an established risk factor for venous thromboembolism (VTE). Moreover, preclinical studies have shown that...
4.
Gupta A, Lam B, Zerbey S, Rosovsky R, Lake L, Dodge L, et al.
Blood Vessel Thromb Hemost
. 2025 Jan;
1(4).
PMID: 39868029
No abstract available.
5.
Chrysafi P, Lam B, Carton S, Patell R
Hamostaseologie
. 2024 Dec;
44(6):429-445.
PMID: 39657652
The high incidence of venous thromboembolism (VTE) globally and the morbidity and mortality burden associated with the disease make it a pressing issue. Machine learning (ML) can improve VTE prevention,...
6.
Barnum K, Patell R, Berry J, Bauer K
J Thromb Haemost
. 2024 Oct;
23(2):404-416.
PMID: 39442623
Splanchnic vein thrombosis (SpVT) is an uncommon site of venous thrombosis that is associated with complications including portal hypertension and hepatic dysfunction. The evaluation and management of this patient population...
7.
Andersen Jr M, Fernandez Turizo M, Dodge L, Hsu C, Barnum K, Berry J, et al.
Blood Adv
. 2024 Oct;
8(24):6151-6160.
PMID: 39418642
Malignancy is a risk factor for splanchnic vein thrombosis (SpVT). Data on the natural history of cancer-associated SpVT are limited. This was a single-center, retrospective cohort study of 581 adult...
8.
Walmsley C, Schoepflin Z, De Brabandt C, Rangachari D, Berwick S, Patell R
Blood Cells Mol Dis
. 2024 Oct;
110:102896.
PMID: 39366077
Hemophagocytic lymphohistiocytosis (HLH) is a severe and often lethal inflammatory syndrome characterized by excessive immune activation leading to fever, cytopenias, and multiorgan involvement. Immune checkpoint inhibitors (ICIs) are central to...
9.
Stafford K, Osataphan S, Patell R, Key N
Haematologica
. 2024 Oct;
110(2):504-506.
PMID: 39363860
No abstract available.
10.
Marquez J, Simon S, Zwicker J, Flaumenhaft R, Hollenbeck B, Patell R
Leuk Res
. 2024 Sep;
146:107591.
PMID: 39332262
No abstract available.